HOME >> BIOLOGY >> NEWS
Vion's TAPET Organisms Demonstrate Reduced Virulence, Increased Safety While Retaining Ability To Specifically Target Tumors

Genetically Modified Salmonella Lack Ability to Induce TNF-Alpha and Cause Sepsis According to Nature Biotechnology Publication

NEW HAVEN, CT (December 29, 1998): New research demonstrates that genetic modification of a cell wall component of tumor-targeting Salmonella bacteria can greatly reduce the bacteria's potential for virulence and ability to cause septic shock, announced Vion Pharmaceuticals, Inc. (Nasdaq: VION). Vion is developing the modified bacteria, the heart of the company's TAPET technology, as vectors for the targeted, systemic delivery of anti-cancer agents to tumors throughout the body.

A publication detailing the research, entitled "Lipid A mutant Salmonella with suppressed virulence and TNF-alpha induction retain tumor-targeting in vivo," will appear in the January issue of the journal Nature Biotechnology. The article is authored by scientists at Vion and their collaborators at Yale University School of Medicine; Texas A&M University, College of Veterinary Medicine; and the University of Washington Health Sciences Center.

Vion researchers and their collaborators have previously reported the development of Salmonella that specifically target tumors over normal tissues. However the clinical utility of such bacteria was potentially limited by the ability of lipid A in the bacteria's cell walls to elicit the production of TNF-alpha and trigger septic shock. Now the researchers have shown that a disruption of the Salmonella msbB gene involved in the production of lipid A reduces, by 10,000 fold, the ability of the bacteria's lipid to induce TNF-alpha and cause death in animal models. At the same time, the msbB-minus Salmonella retain their tumor-targeting properties, exhibiting the ability to accumulate in tumors at ratios in excess of 1000:1 compared with normal tissues.

"Administration of these modified bacteria to mice bearing melanoma tumors results in tumors that are less than six percent the size of tumors in unt
'"/>

Contact: Joan Kureczka
JKureczka@aol.com
415-821-2413
Kureczka/Martin Associates
29-Dec-1998


Page: 1 2 3 4

Related biology news :

1. Vions TAPET® administered to first patients in Phase I human intratumoral safety trial at the Cleveland Clinic Foundation
2. Software Helps Decipher Genomes Of Higher Organisms
3. The Fire Down Below: Extreme Heat-Loving Organisms May Be Keys To Molecular Evolution, Origin Of Life, New Book Argues
4. Virginia Tech Scientists To Evaluate Risks Associated With Release of Recombinant Organisms
5. Transposable Elements May Have Had A Major Role In The Evolution Of Higher Organisms
6. Vion Demonstrates Readiness Of First Tumor-Targeting Salmonella For Human Testing Against Solid Tumors
7. Emory University Scientists Demonstrate New Pathway For Genetic Mutations In Everyday Cell Life
8. Wake Forest Physicians Demonstrate How Gene-Diet Interaction Affects Cholesterol Absorption
9. Ribozyme Pharmaceuticals, Inc. Demonstrates Potent Activity Of A Ribozyme Targeted Against The Hepatitis C Virus
10. Engineering Animation, Inc. Demonstrates Internet Anatomy At Visible Human Project Conference
11. Study Demonstrates High Conservation Potential Of Logged Rainforest

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/18/2019)... LONG BEACH, Calif. (PRWEB) , ... June 18, ... ... provider of multi-GPU deep learning cloud solutions, today introduced Data Science Workstations-as-a-Service as ... data science workstation hardware from BOXX Technologies, Cirrascale Data Science Workstations feature NVIDIA® ...
(Date:6/14/2019)... ... , ... Molecular diagnostics segment is the fastest-growing segment within the global IVD ... segments that are expected to drive the growth are infectious diseases, cancer, and transplant ... Kalorama’s The World Molecular Diagnostics Market, 8th Edition . , The discovery of ...
(Date:6/11/2019)... ... June 12, 2019 , ... With a rapidly growing ... leverage the Geneious Biologics platform as a premium hub for bioinformatics and computer ... says: “The Geneious team has done an excellent job accommodating our specific data, ...
Breaking Biology News(10 mins):
(Date:5/31/2019)... ... May 30, 2019 , ... A study released ... delivery system for the sustained release of human placental stem cell (HPSC)-derived conditioned ... able to deliver CM into the injured kidney, where it helped restore function ...
(Date:5/14/2019)... ... May 13, 2019 , ... Leak Detection ... for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries’ is excited to ... aims to improve LDA’s ability to communicate directly with the marketplace; serving as ...
(Date:5/4/2019)... , ... May 03, 2019 , ... ... release of the Diopsys® ffERG/Photopic Negative Response vision test, a new ... By 2050, it is estimated that 6.3 million Americans will have glaucoma, with ...
(Date:5/2/2019)... ... May 02, 2019 , ... Boston Robotic ... Boston area. Gone are the days of painful hair transplant procedures. Boston Robotic ... System is the only robotic intelligent solution to offer a minimally invasive procedure. ...
Breaking Biology Technology:
Cached News: